Functional Imaging
Functional neuroimaging spans research and clinical applications with growing clinical translation. The session covers fMRI in pre-surgical planning (language and motor mapping), FDG-PET in dementia diagnostic algorithms, amyloid PET (florbetaben, florbetapir) and tau PET (flortaucipir, MK-6240) imaging in Alzheimer's, dopamine transporter imaging (DaTscan, ioflupane) in Parkinsonism differentiation, connectivity-based functional MRI in psychiatry and OCD/depression, and DBS targeting imaging. Discussion addresses 7T MRI clinical applications, brain-machine interface preparation imaging, the role of imaging in DBS programming optimisation, dopaminergic vs noradrenergic imaging, novel tracers in neurology, and emerging imaging biomarkers for neurodegenerative disease.
- fMRI for pre-surgical planning
- FDG-PET in dementia
- Amyloid and tau PET
- DaTscan in Parkinsonism
- Connectivity fMRI
- 7T MRI applications
- BCI preparation imaging
- Novel neurology tracers
Explore the full GCNN 2027 program
- 01Stroke & Cerebrovascular Disease
- 02Alzheimer’s & Dementia
- 03Multiple Sclerosis
- 04Parkinson’s & Movement Disorders
- 05Epilepsy
- 06Neuromuscular Disease
- 07Headache Medicine
- 08Neuro-Oncology
- 09Clinical Neuroscience & AI
- 10Spinal Cord Injury
- 11Traumatic Brain Injury
- 12Sleep Disorders
- 13Neuropathic Pain
- 14Cerebellar & Ataxia Disorders
- 15Functional Neurological Disorders
- 16Pediatric Neurology
- 17Neuroimmunology
- 18Brain-Computer Interfaces
- 19Migraine
- 20Cluster Headache
- 21Dementia with Lewy Bodies
- 22Frontotemporal Dementia
- 23Huntington Disease
- 24ALS
- 25Tremor & Dystonia
- 26Restless Legs Syndrome
- 27Neuroinfectious Disease
- 28Brain Tumors
- 29Vestibular Disorders
- 30Autonomic Disorders
- 32Neuro-Ophthalmology
- 33Neuropsychology
- 34Movement Disorder Surgery
- 35Genetic Counselling